FDA
-
-
-
-
-
-
-
Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths
-
-
-
-
-
-
-
FDA tightens requirements for COVID vaccine, adding trials for healthy adults
-
-
-
-
-
-
-
FDA Asks Novavax (NVAX) to Complete New Study for Delayed Covid-19 Shot's Approval, Sources Say -- WSJ
-
-
-
-
-
-
-
Novavax (NVAX) Announces Changes to Board of Directors
-
-
-
-
-
-
-
Novavax (NVAX) Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
-
-
-
-
-
-
-
Novavax (NVAX) PT Lowered to $25 at Jefferies
-
-
-
-
-
-
-
Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

